Guidelines for the management of uveitis in Internal Medicine;Uvéites et médecine interne : stratégies diagnostique et thérapeutique

Revue de Medecine Interne

Volumn 30, Issue 6, 2009, Pages 492-500

  Abad, S ^a   Seve P ^b   Dhote, R ^a   Brezin A P ^c  

^a UPRES   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Anti TNF therapy; Corticosteroids; Diagnostic procedure; Immunosuppressive agents; Uveitis

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; SALAZOSULFAPYRIDINE; TRIAMCINOLONE;

DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EYE EXAMINATION; EYE INFLAMMATION; HEALTH CARE PERSONNEL; HEALTH CENTER; HUMAN; MEDICAL LITERATURE; MEDICAL PRACTICE; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PROGNOSIS; SARCOIDOSIS; SHORT SURVEY; UVEITIS;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERNAL MEDICINE; PHYSICIAN'S ROLE; UVEITIS;

EID: 65849527281     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2008.08.011     Document Type: Short Survey

References (51)

1. Gritz D.C., and Wong I.G. Incidence and prevalence of uveitis in Northern California: the Northern California epidemiology of uveitis study. Ophthalmology 111 (2004) 491-500
2. Suttorp-Schulten M.S., and Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 80 (1996) 844-848
3. Jabs D.A., Nussenblatt R.B., Rosenbaum J.T., and Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140 (2005) 509-516
4. Rothova A., Suttorp-van Schulten M.S., Frits Treffers W., and Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 80 (1996) 332-336
5. Bodaghi B., Cassoux N., Wechsler B., Hannouche D., Fardeau C., Papo T., et al. Chronic severe uveitis etiology and visual outcome in 927 patients from a single center. Medicine 80 (2001) 263-270
6. Monnet D., Breban M., Hudry C., Dougados M., and Brezin A.P. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 Uveitis. Ophthalmology 111 (2004) 802-809
7. Rudwaleit M., Van der Heijde D., Khan M.A., Braun J., and Sieper J. How to diagnose axial spondylathritis early?. Ann Rheum Dis 63 (2004) 535-543
8. International Study Group for Behçet's Disease. Evaluation of diagnostic (classification) criteria in Behçet's disease: toward internationally agreed criteria. Lancet 335 (1990) 1078-1080
9. Tugal-Tutkun I., Onal S., Altan-Yaycioglu R., Huseyin Altunbas H., and Urgancioglu M. Uveitis in Behçet disease: an analysis of 880 patients. Am J Ophthalmol 138 (2004) 373-380
10. Abad S., Monnet D., Caillat Zucman S., Mrejen S., Blanche P., Chalumeau M., et al. Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations and HLA genotype data. Ocul Inflamm Immunol 16 (2008) 3-8
11. Read R.W., Holland G.N., Rao N.A., Tabbara K.F., Ohno S., Arellanes-Garcia L., et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131 (2001) 647-652
12. Mandeville J.TH., Levinson R.D., and Holland G.N. The tubulointerstitial nephritis and uveitis syndrome. Surv Ophthalmol 46 (2001) 195-208
13. Park S., Abad S., Monnet D., Tulliez M., Merlat A., Gyan E., et al. Pseudo-uveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients. Medicine (Baltimore) 83 (2004) 223-232
14. Finger P.T., Papp C., Latkany P., Kurli M., and Iacob C.E. Anterior chamber paracentesis cytology (cytospin technique) for the diagnosis in intraocular lymphoma. Br J Ophthalmol 90 (2006) 690-692
15. Karma A., von Willebrand E.O., Tommila P.V., Paetau A.E., Oskala P.S., and Immonen I.J. Primary intraocular lymphoma: improving the diagnostic procedure. Ophthalmology 114 (2007) 1372-1377
16. Cassoux N., Giron A., Bodaghi B., Tran T.H., Baudet S., Davy F., et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 48 (2007) 3253-3259
17. Lardenoy C.W.T.A., Van der Lelij A., de Loos W.S., Treffers W.F., and Rothova A. Peripheral multifocal chorioretinitis. A distinct clinical entity?. Ophthalmology 104 (1997) 1820-1826
18. Kaiser P.K., Lowder C.Y., Sullivan P., Sanislo S.R., Kosmorsky G.S., Meziane M.A., et al. Chest computed tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol 133 (2002) 499-505
19. 67Ga scintigraphy in patients with sarcoidosis. J Nucl Med 47 (2006) 1571-1576
20. P Sève, C Billotey, L Varron, M Janier, JD Grange, C Broussolle, et al. Fluorodeoxyglucose positron emission tomography for the diagnosis of suspected uveitis-associated sarcoidosis in patients with normal chest computerized tomography. International Ocular Inflammation Society, 9th Congress, Paris, September 2007.
21. Abad S., Meyssonier V., Allali J., Gouya H., Monnet D., Parc C., et al. Association of peripheral multifocal choroiditis with sarcoidosis? A study of 37 patients. Arthritis Rheum 51 (2004) 974-982
22. Morimura Y., Okada A.A., Kawahara S., Miyamoto Y., Kawai S., Hirakata A., et al. Tuberculin skin testing in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology 109 (2002) 851-857
23. Cunningham E.T., and Koehler J.E. Ocular bartonellosis. Am J Ophthalmol 130 (2000) 340-349
24. Donahue S.P., Greven C.M., Zuravleff J.J., Eller A.W., Nguyen M.H., Peacock J.E., et al. Intraocular candidiasis in patients with candidemia: clinical implications derived from a prospective multicenter study. Ophthalmology 101 (1994) 1302-1309
25. Stewart J.M., Cubillan L.D., and Cunningham Jr. E.T. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina 25 (2005) 1005-1013
26. Bugage R.R. Ocular manifestations of human T-cell lymphotropic virus type 1 infection. Curr Opin Ophthalmol 14 (2003) 420-425
27. Dabil H., Boley M.L., Schmitz T.M., and Van Gelder R.N. Validation of a diagnostic multiplex polymerase chain reaction assay for infectious posterior uveitis. Arch Ophthalmol 119 (2001) 1315-1322
28. Chee S.P., Bacsal K., Jap A., Se-Thoe S.Y., Cheng C.L., and Tan B.H. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. Am J Ophthalmol 145 (2008) 834-840
29. Westeneng A.C., Rothova A., de Boer J.H., and de Groot-Mijnes J.D. Infectious uveitis in immunocompromised patients and the diagnostic value of polymerase chain reaction and Goldmann-Witmer coefficient in aqueous analysis. Am J Ophthalmol 144 (2007) 781-785
30. Ortega-Larrocea G., Bobadilla-del-Valle M., Ponce-de-Leon A., and Sifuentes-Osornio J. Nested polymerase chain reaction for Mycobacterium tuberculosis DNA detection in aqueous and vitreous of patients with uveitis. Arch Med Res 34 (2003) 116-119
31. Bodaghi B., Dauga C., Cassoux N., Wechsler B., Merle-Beral H., Poveda J.D., et al. Whipple's syndrome (uveitis, B27-negative spondylarthropathy, meningitis, and lymphadenopathy) associated with Arthrobacter sp. infection. Ophthalmology 105 (1998) 1891-1896
32. Acharya N., Lietman T., Cevallos V., Whitcher J.P., Saidel M., Stone D., et al. Correlation between clinical suspicion and polymerase chain reaction verification of infectious vitritis. Am J Ophthalmol 141 (2006) 584-585
33. Kok H., Lau C., Maycock N., McCluskey P., and Lightman S. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 112 (2005) 1916-1921
34. Benitez-Del-Castillo J.M., Garcia-Sanchez J., Iradier T., and Bañares A. Sulfasalazine in the prevention of anterior uveitis associated with ankylosing spondylitis. Eye 14 (2000) 340-343
35. Muñoz-Fernández S., Hidalgo V., Fernández-Melón J., Schlincker A., Bonilla G., Ruiz-Sancho D., et al. Sulfasalazine reduces the number of flares of acute anterior uveitis over a one-year period. J Rheumatol 30 (2003) 1277-1279
36. Samson C.M., Waheed N., Baltatzis S., and Foster C.S. Methotrexate therapy for chronic noninfectious uveitis. Analysis of a case series of 160 patients. Ophthalmology 108 (2001) 1134-1139
37. Baughman R.P., Winget D.B., and Lower E.E. Methotrexate is steroid sparing in acute sarcoidosis: results of double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 17 (2000) 60-66
38. Baker K.B., Spurrier N.J., Watkins A.S., Smith J.R., and Rosenbaum J.T. Retention time for corticosteroid-sparing systemic immunosuppressive agents in patients with inflammatory eye disease. Br J Ophthalmol 90 (2006) 1481-1485
39. Dinning W. An overview of ocular manifestations. In: Lehner T., and Barnes C. (Eds). Recent advances in Behçet's disease (1986), Royal Society of Medicine Services, London 227-233
40. Yazici H., Pazarli H., Barnes C.G., Tuzun Y., Ozyazgan Y., Silman A., et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 322 (1990) 281-285
41. Ozyazgan Y., Yurdakul S., Yazici H., Tuzun B., Iscimen A., Tuzun Y., et al. Low dose cyclosporin A versus pulsed cyclosphosphamide in Behçet's syndrome: a single masked trial. Br J Ophthalmol 76 (1992) 241-243
42. Demiroglu H., Ozcebe O.I., Barista I., Dundar S., and Eldem B. Interferon alfa-2b, colchicine, and benzathine penicillin in Behçet's disease: a randomised trial. Lancet 355 (2000) 605-609
43. Kötter I., Zierhut M., Eckstein A.K., Vonthein R., Ness T., Günaydin I., et al. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87 (2003) 423-431
44. Bodaghi B., Gendron G., Wechsler B., Terrada C., Cassoux N., Huong du L.T., et al. Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients. Br J Ophthalmol 91 (2007) 335-339
45. Sfikakis P.P., Kaklamanis P.H., Elezoglou A., Katsilambros N., Theodossiadis P.G., Papaefthimiou S., et al. Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease. Ann Intern Med 140 (2004) 404-406
46. Ohno S., Nakamura S., Hori S., Shimakawa M., Kawashima H., Mochizuki M., et al. Efficacy, safety, and pharmakokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol 31 (2004) 1362-1368
47. Tugal-Tutkun I., Mudun A., Urgancioglu M., Kamali S., Kasapoglu E., Inanc M., et al. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine and corticosteroids in Behçet's disease. Arthritis Rheum 52 (2005) 2478-2484
48. Sfikakis P.P., Markomichelakis N., Alpsoy E., Assaad-Khalil S., Bodaghi B., Gul A., et al. Anti-TNF therapy in the management of Behcet's disease-review and basis for recommendations. Rheumatology 46 (2007) 736-741
49. Suhler E.B., Smith J.R., Wertheim M.S., Lauer A.K., Kurz D.E., Pickard T.D., et al. A prospective trial of infliximab therapy for refractory uveitis. Arch Ophthalmol 123 (2005) 903-912
50. Hochberg M.C., Lebwohl M.G., Plevy S.E., Hobbs K.F., and Yocum D.E. The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arthritis Rheum 34 (2005) 819-836
51. Lim L., Suhler E.B., and Smith J.R. Biologic therapies for inflammatory eye disease. Clin Experiment Ophthalmol 34 (2006) 365-374